Prospects for passage of Democratic drug pricing legislation as part of the Build Back Better (BBB) Act dimmed again last week with news that Sen. Ben Ray Lujan (D-N.M.) had a stroke on Jan 27.
Lujan’s chief of staff said on Feb. 1 that the senator is expected to make a full recovery. A senior Lujan aide told The Atlantic magazine that, barring complications, Lujan could return to work in four to six weeks.
Prospects for passage of Democratic drug pricing legislation as part of the Build Back Better (BBB) Act dimmed again last week with news that Sen. Ben Ray Lujan (D-N.M.) had a stroke on Jan 27.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.